Dermata Therapeutics GAAP EPS of -$8.16
Source: SeekingAlpha
2026-03-27 10:16:03 ET
More on Dermata Therapeutics
- Seeking Alpha’s Quant Rating on Dermata Therapeutics
- Historical earnings data for Dermata Therapeutics
- Financial information for Dermata Therapeutics
Read the full article on Seeking Alpha
For further details see:
Dermata Therapeutics GAAP EPS of -$8.16
Dermata Therapeutics Inc.
NASDAQ: DRMA
DRMA Trading
-3.03% G/L:
$1.28 Last:
43,268 Volume:
$1.30 Open:
DRMA Latest News
May 13, 2026 04:05:00 pm
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
April 02, 2026 08:30:00 am
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
March 26, 2026 05:15:00 pm
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
DRMA Stock Data
$4,791,730
2,386,624
3.53%
6
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
